Zhengye Biotechnology Closes IPO
Ticker: ZYBT · Form: 6-K · Filed: Jan 8, 2025 · CIK: 1975641
| Field | Detail |
|---|---|
| Company | Zhengye Biotechnology Holding Ltd (ZYBT) |
| Form Type | 6-K |
| Filed Date | Jan 8, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.000025, $4.00 |
| Sentiment | bullish |
Sentiment: bullish
Topics: ipo, offering, biotechnology
TL;DR
Zhengye Biotech IPO closed Jan 8, 2025, selling 1.5M shares.
AI Summary
Zhengye Biotechnology Holding Limited announced the closing of its initial public offering (IPO) on January 8, 2025. The company successfully sold 1,500,000 ordinary shares, each with a par value of $0.000025, as part of this offering.
Why It Matters
The successful completion of an IPO provides Zhengye Biotechnology with capital for growth and increases its visibility in the public markets.
Risk Assessment
Risk Level: medium — As a newly public company, Zhengye Biotechnology faces the inherent risks associated with market volatility and establishing its market position.
Key Numbers
- 1,500,000 — Ordinary Shares Sold (Represents the total number of shares offered and sold in the IPO.)
- $0.000025 — Par Value Per Share (The nominal value assigned to each ordinary share.)
Key Players & Entities
- Zhengye Biotechnology Holding Limited (company) — The company that closed its IPO.
- January 8, 2025 (date) — Date of IPO closing.
- 1,500,000 (dollar_amount) — Number of ordinary shares sold in the IPO.
- $0.000025 (dollar_amount) — Par value per ordinary share.
FAQ
What was the total number of ordinary shares sold in Zhengye Biotechnology's IPO?
Zhengye Biotechnology sold 1,500,000 ordinary shares in its IPO.
On what date did Zhengye Biotechnology's IPO close?
The IPO closed on January 8, 2025.
What is the par value of each ordinary share offered by Zhengye Biotechnology?
The par value of each ordinary share is $0.000025.
Under which form was Zhengye Biotechnology's IPO registration statement initially filed?
The IPO registration statement was initially filed on Form F-1 (File No. 333-276436).
What is the principal executive office address for Zhengye Biotechnology Holding Limited?
The principal executive office is located at No.1 Lianmeng Road, Jilin Economic & Technical Development Zone, Jilin City, Jilin Province, China.
Filing Stats: 487 words · 2 min read · ~2 pages · Grade level 12.2 · Accepted 2025-01-08 16:10:30
Key Financial Figures
- $0.000025 — of 1,500,000 ordinary shares, par value $0.000025 per share (the “ Ordinary Shares
- $4.00 — 024. The Ordinary Shares were priced at $4.00 per share, and the offering was conduct
Filing Documents
- ea0227195-6k_zhengye.htm (6-K) — 18KB
- ea022719501ex10-1_zhengye.htm (EX-10.1) — 243KB
- ea022719501ex99-1_zhengye.htm (EX-99.1) — 10KB
- ea022719501ex99-2_zhengye.htm (EX-99.2) — 10KB
- 0001213900-25-002076.txt ( ) — 283KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Zhengye Biotechnology Holding Limited By: /s/ Songlin Song Name: Songlin Song Title: Chief Executive Officer Date: January 8, 2025 2 EXHIBIT INDEX Exhibit No. Description 10.1 Underwriting Agreement dated January 6, 2025, by and between the Company and Representative 99.1 Press Release dated January 6, 2025, announcing the pricing of the IPO 99.2 Press Release dated January 8, 2025, announcing the closing of the IPO 3